1. Home
  2. LGVN vs FEDU Comparison

LGVN vs FEDU Comparison

Compare LGVN & FEDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGVN
  • FEDU
  • Stock Information
  • Founded
  • LGVN 2014
  • FEDU 2007
  • Country
  • LGVN United States
  • FEDU China
  • Employees
  • LGVN N/A
  • FEDU N/A
  • Industry
  • LGVN Medicinal Chemicals and Botanical Products
  • FEDU
  • Sector
  • LGVN Health Care
  • FEDU
  • Exchange
  • LGVN Nasdaq
  • FEDU NYSE
  • Market Cap
  • LGVN 23.4M
  • FEDU 19.9M
  • IPO Year
  • LGVN 2021
  • FEDU 2017
  • Fundamental
  • Price
  • LGVN $1.23
  • FEDU $9.77
  • Analyst Decision
  • LGVN Strong Buy
  • FEDU
  • Analyst Count
  • LGVN 3
  • FEDU 0
  • Target Price
  • LGVN $8.67
  • FEDU N/A
  • AVG Volume (30 Days)
  • LGVN 132.9K
  • FEDU 1.8K
  • Earning Date
  • LGVN 05-08-2025
  • FEDU 06-26-2025
  • Dividend Yield
  • LGVN N/A
  • FEDU 23.35%
  • EPS Growth
  • LGVN N/A
  • FEDU N/A
  • EPS
  • LGVN N/A
  • FEDU 0.12
  • Revenue
  • LGVN $2,225,000.00
  • FEDU $27,971,139.00
  • Revenue This Year
  • LGVN N/A
  • FEDU N/A
  • Revenue Next Year
  • LGVN $24.82
  • FEDU N/A
  • P/E Ratio
  • LGVN N/A
  • FEDU $84.74
  • Revenue Growth
  • LGVN 127.50
  • FEDU 141.14
  • 52 Week Low
  • LGVN $0.77
  • FEDU $3.69
  • 52 Week High
  • LGVN $6.40
  • FEDU $22.70
  • Technical
  • Relative Strength Index (RSI)
  • LGVN 39.93
  • FEDU 64.35
  • Support Level
  • LGVN $1.25
  • FEDU $9.00
  • Resistance Level
  • LGVN $1.37
  • FEDU $10.50
  • Average True Range (ATR)
  • LGVN 0.09
  • FEDU 0.38
  • MACD
  • LGVN -0.01
  • FEDU 0.01
  • Stochastic Oscillator
  • LGVN 30.00
  • FEDU 59.79

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

About FEDU FOUR SEASONS EDUCATION (CAYMAN) INC SPON ADS EACH REP 10 ORD SHS(R/S)

Four Seasons Education (Cayman) Inc is engaged in the provision of after-school education services for kindergarten, elementary and middle school students. The Company derives its revenue from learning services, tourism services, and learning technology and content solutions. The company is a comprehensive educational enterprise that provides research practice services, educational informatization equipment, high-quality educational resources, and teacher training, as well as a digital publishing business, and continues to expand in educational research and educational informatization.

Share on Social Networks: